Non specific esterase is positive in all categories of AML except:

**Core Concept**
Non-specific esterase (NSE) is a cytochemical marker used to identify and classify acute myeloid leukemia (AML) cells. It is a critical tool in the diagnosis and subtyping of AML, helping to distinguish between different categories of the disease.

**Why the Correct Answer is Right**
Non-specific esterase activity is typically present in monocytic and myelomonocytic AML cells, which express the enzyme due to the presence of monocytic differentiation markers. This is because NSE is a lysosomal enzyme involved in the breakdown of cellular components. In contrast, acute erythroid leukemia (M6) and acute megakaryoblastic leukemia (M7) do not typically express NSE, as these cell types have distinct differentiation pathways that do not involve monocytic differentiation.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not provided, but if it were a correct option, it would likely be one of the monocytic or myelomonocytic subtypes, such as M4 or M5, which do express NSE.
* **Option B:** This option is also not provided, but it could be a subtype of AML that expresses NSE, such as M3 (acute promyelocytic leukemia), which has some monocytic differentiation.
* **Option C:** This option is not provided, but it might be a subtype of AML that does not express NSE, such as M2 (acute myeloblastic leukemia with maturation), which has some granulocytic differentiation.

**Clinical Pearl / High-Yield Fact**
When using non-specific esterase staining to diagnose AML, it is essential to consider the clinical and morphological features of the patient's blood and bone marrow cells, as well as the results of other cytochemical stains. This will help to accurately subtype the disease and guide treatment decisions.

**Correct Answer:** D.